Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases

BACKGROUND: Kras mutation has been associated with shorter overall survival and time to disease recurrence after resection of colorectal liver metastases (CLM). This study evaluated the prognostic value of Kras mutation in patients with CLM treated by percutaneous radiofrequency ablation (RFA). METH...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Shady, Waleed, Petre, Elena N., Vakiani, Efsevia, Ziv, Etay, Gonen, Mithat, Brown, Karen T., Kemeny, Nancy E., Solomon, Stephen B., Solit, David B., Sofocleous, Constantinos T.
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2017
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630397/
https://ncbi.nlm.nih.gov/pubmed/29029497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19806
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items